Tien Liang BioTech Co (ROCO:4127) Total Inventories: NT$67.0 Mil (As of Dec. 2025)


ROCO:4127 Tien Liang BioTech Co Ltd ROCO:4127
38 GF Score
Price NT$68.50
GF Value NT$39.20
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Tien Liang BioTech Co Total Inventories?

Tien Liang BioTech Co ROCO:4127 +6.20% 38 Total Inventories is NT$67.0 Mil as of Dec. 2025. GuruFocus rates ROCO:4127 with a GF Score™ of 38/100 and a GF Value™ of NT$39.20 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Tien Liang BioTech Co's total inventories for the quarter that ended in Dec. 2025 was NT$67.0 Mil. Tien Liang BioTech Co's average total inventories from the quarter that ended in Sep. 2025 to the quarter that ended in Dec. 2025 was NT$64.6 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Tien Liang BioTech Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was NT$-10.73.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tien Liang BioTech Co's Days Inventory for the three months ended in Dec. 2025 was 102.77.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tien Liang BioTech Co's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.89.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tien Liang BioTech Co's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.49.

Tien Liang BioTech Co  (ROCO:4127) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Tien Liang BioTech Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

Net-Net Working Capital Per Share (Q: Dec. 2025 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(152.311+0.75 * 43.002+0.5 * 67.042-709.189
-0-0)/45.760
=-10.73

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tien Liang BioTech Co's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2025 )/Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=64.589/57.35*365 / 4
=102.77

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tien Liang BioTech Co's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2025 ) / Average Total Inventories (Q: Dec. 2025 )
=57.35 / 64.589
=0.89

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tien Liang BioTech Co's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=64.589 / 131.653
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Tien Liang BioTech Co Total Inventories Related Terms

Tien Liang BioTech Co Total Inventories Historical Data

* Premium members only.

The historical data trend for Tien Liang BioTech Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tien Liang BioTech Co Total Inventories Chart

Tien Liang BioTech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.95 94.97 75.80 58.49 67.04

Tien Liang BioTech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.49 60.46 64.62 62.14 67.04
ROCO:4127
38GF Score
Tien Liang BioTech Co Ltd ROCO:4127
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tien Liang BioTech Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of NT$67.0 Mil mean?
Tien Liang BioTech Co (ROCO:4127) has a Total Inventories of NT$67.0 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Tien Liang BioTech Co and its competitors.
Is Tien Liang BioTech Co's Total Inventories too high?
Tien Liang BioTech Co's current Total Inventories is NT$67.0 Mil. Overall, Tien Liang BioTech Co has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tien Liang BioTech Co's Total Inventories compare to ZTS and UTHR?
Tien Liang BioTech Co's Total Inventories of NT$67.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Tien Liang BioTech Co and its competitors. Tien Liang BioTech Co's current Total Inventories is NT$67.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tien Liang BioTech Co stock overvalued right now?
Based on GuruFocus' analysis, Tien Liang BioTech Co (ROCO:4127) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$39.20, compared to a current price of NT$68.50 — trading 74.7% above its estimated fair value. The current Total Inventories is NT$67.0 Mil. Tien Liang BioTech Co's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Tien Liang BioTech Co (ROCO:4127), the current Total Inventories is NT$67.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tien Liang BioTech Co (ROCO:4127) Overvalued in 2026?

Based on GuruFocus' analysis, Tien Liang BioTech Co stock appears to be overvalued. The current stock price of NT$68.50 is trading 74.7% above its estimated GF Value™ of NT$39.20. GuruFocus considers Tien Liang BioTech Co to be Significantly Overvalued.

Key valuation signals for ROCO:4127:

  • Total Inventories: NT$67.0 Mil
  • GF Value™: NT$39.20 vs. price of NT$68.50 (74.7% above fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tien Liang BioTech Co Business Description

Address No. 147, Section 1, Datong Road, 9th Floor, Xizhi District, New Taipei City, TWN
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical, and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis, and hepatic diseases.
38GF Score

Get the complete analysis for ROCO:4127

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$68.50
Price
NT$39.20
GF Value